Award
National Cancer Institute 5R01CA258997-05
Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays
Recipient
University of Washington, Seattle, WA, United States
Award Amount
$379,304.00
Ceiling
$379,304.00
Awarded
March 04, 2026
Identifier
5R01CA258997-05
The award supports research to develop combined PET imaging and immunologic biomarker signatures to improve treatment response assessment and patient stratification in metastatic non-small cell lung cancer undergoing chemo-immunotherapy and radiation therapy.
Description
This project focuses on developing biomarkers for response to combined immunotherapy and radiation in lung cancer, aiming to improve patient outcomes through personalized treatment strategies. It involves assessing and monitoring treatment response by combining PET imaging and circulating immunologic biomarkers to stratify patients and support precision therapy.